Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-03-02Clinical Trial Update: Insulin Resistance and Insulin Secretion [NA]
A clinical trial investigating insulin resistance and insulin secretion in Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-24Clinical Trial Update: Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Type II Diabetes [NA]
A clinical trial evaluating the safety and effects of autologous adipose-derived stromal cells delivered to patients with Type 2 diabetes ha…
-
CLINICAL_TRIALS withdrawal · 2017-10-20Clinical Trial Update: Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus [Phase 4]
Alogliptin Phase 4 trial in Indian participants with type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-20Clinical Trial Update: An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms
An exploratory clinical trial to collect whole blood samples for analyzing genetic polymorphisms was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-10-12Clinical Trial Update: Effects of Canagliflozin on Intravascular Volume and Hemodynamics [Phase 4]
A Phase 4 trial evaluating the effects of canagliflozin on intravascular volume and hemodynamics has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-10-02Clinical Trial Update: Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II Diabetics [Phase 4]
A Phase 4 trial evaluating aliskiren versus hydrochlorothiazide in hypertensive patients with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-17Clinical Trial Update: Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study [Phase 2]
This clinical trial update reports that the Phase 2 study evaluating liraglutide for psoriatic arthritis (and related conditions) has been w…
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy [Phase 1]
This clinical trial update indicates that a Phase 1 study of a new insulin for Type 2 diabetes patients on insulin injections has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-06-01Clinical Trial Update: Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes Mellitus [EARLY_Phase 1]
A Phase 1 study evaluating the effects of DPP-4 inhibition on calcium and bone metabolism in Type 2 diabetes mellitus has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-17Clinical Trial Update: Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics [NA]
The clinical trial evaluating whether ranolazine reduces biomarkers of myocardial damage in patients with silent myocardial ischemia and typ…
-
CLINICAL_TRIALS withdrawal · 2017-04-26Clinical Trial Update: Enhanced Multicenter Dietary Portfolio Study [NA]
The Enhanced Multicenter Dietary Portfolio Study has been withdrawn. It involved conditions including cardiovascular diseases, Type 2 diabet…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: Hartmann's Solution and Normal Saline in Type II Diabetes Patients [NA]
A clinical trial comparing Hartmann's Solution to Normal Saline in adults with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery [Phase 4]
A Phase 4 clinical trial evaluating safety and efficacy of correcting hyperglycemia in patients with Type 1 or Type 2 diabetes undergoing ou…
-
CLINICAL_TRIALS withdrawal · 2017-03-15Clinical Trial Update: Measuring Patient Engagement in Diabetes Care
A Northwestern University clinical trial assessing patient engagement in type 2 diabetes care has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes [Phase 4]
Phase 4 trial of Exenatide-LAR combined with dapagliflozin in overweight/obese patients with Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-03-01Clinical Trial Update: The Effect of add-on Canagliflozin in Patients With Type 2 Diabetes Treated With U-500 Insulin [Phase 4]
A Phase 4 trial investigating add-on canagliflozin in Type 2 diabetes patients treated with U-500 insulin has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-13Clinical Trial Update: IL-1RA, Acute Exercise, and Beta-cell Function [NA]
A clinical trial evaluating interleukin-1 receptor antagonist (anakinra) effects on beta-cell function during acute exercise in people with …
-
CLINICAL_TRIALS withdrawal · 2017-02-10Clinical Trial Update: A Smartphone Application to Improve Medication Adherence Among People With Type 2 Diabetes Mellitus in Singapore [NA]
A trial evaluating a smartphone application to improve medication adherence in people with Type 2 diabetes mellitus in Singapore has been wi…
-
CLINICAL_TRIALS withdrawal · 2016-12-26Clinical Trial Update: Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass [NA]
A Duke University-sponsored trial investigating intestinal remodeling and glucose metabolism after Roux-en-Y gastric bypass has been withdra…
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of Alegitazar in Patients With Type 2 Diabetes And Chronic Kidney Disease (Alerenal Study) [Phase 3]
A Phase 3 trial of Alegitazar in patients with Type 2 diabetes mellitus and chronic kidney disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-11-02Clinical Trial Update: A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin [Phase 2]
A Phase 2 trial of RO6811135 in patients with Type 2 diabetes mellitus inadequately controlled with metformin has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-25Clinical Trial Update: A Pilot Feasibility Study of Fibroblast Calcium and Glucoregulation in Health and Disease
The pilot feasibility trial on fibroblast calcium and glucoregulation for Type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Cochlear-Vestibular Ganglion (CVG) in Newly Diagnosed Type 2 Diabetes Patients [NA]
A clinical trial investigating Cochlear-Vestibular Ganglion (CVG) in newly diagnosed Type 2 diabetes mellitus patients was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-05Clinical Trial Update: Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI [Phase 4]
This clinical trial update reports that the Phase 4 study evaluating the DPP-4 inhibitor sitagliptin for non-alcoholic fatty liver disease i…
-
CLINICAL_TRIALS withdrawal · 2016-09-14Clinical Trial Update: An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System [NA]
An open-label extension study for the EndoBarrier Gastrointestinal Liner System has been withdrawn from the trial.